Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies

Clinical trial NCT05370469 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05370469
Sponsor: University of Virginia
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer EGFR Gene Mutation EGFR ALK Gene Mutation RET Gene Mutation MET Gene Mutation KRAS Mutation-Related Tumors BRAF ROS1 Gene Mutation

Start date: 2022-08-25
Primary completion: 2024-06-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.